In addition, the atrophic effect of KDM5A and LSD2 inhibition using siRNA on both A498 and ACHN cell growth by inducing early apoptosis with the concomitant arrest of RCC cells at different phases of the cell cycle overlay the first step towards their therapeutic potential in ccRCC. Here, KDM5A is linked to renal cell carcinoma.